FNY Investment Advisers’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

FNY Investment Advisers’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-57,172	Closed	-$1.38M	–	774
2023 Q1	$1.38M	Buy	+57,172	New	+$717K	1.58%	11

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FNY Investment Advisers's PRVB Position: Q2 2023 in Review

FNY Investment Advisers sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 57,172 shares — an estimated $1.38M sold.

FNY Investment Advisers first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $1.38M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

FNY Investment Advisers reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
FNY Investment Advisers sold 57,172 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.38M.
FNY Investment Advisers first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
FNY Investment Advisers's Provention Bio, Inc. Common Stock position peaked at $1.38M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on FNY Investment Advisers's 13F filing for Q2 2023, filed 11 Jul 2023.